Press Kit

MassBio represents 1,000+ life sciences companies and organizations involved with the industry. We are available to comment and provide background on public policy, economic development, education, workforce development and other key life sciences issues.

MassBio in the News

BILLERICA, Mass., May 2, 2016 /PRNewswire/ -- EMD Serono, the biopharmaceutical business of Merck KGaA, Darmstadt, Germany, in North America, today announced a $12 million investment for the expansion of its R&D facility... Read More

Greater Boston’s strength in the life sciences is on display in a new report to come out this morning showing the region leads the world in the key employment area of early stage biotech research and is among the leading... Read More

A candidate for an open Florida congressional seat who’s being touted as “the first-ever M.D., Ph.D. and champion of biotechnology” if elected to the seat, met with several biotech leaders last night in Boston Read More

A candidate for an open Florida congressional seat who’s being touted as “the first-ever M.D., Ph.D. and champion of biotechnology” if elected to the seat, met with several biotech leaders last night in Boston Read More

BOSTON, March 15, 2016 /PRNewswire/ -- Today, Bayer brings together more than 150 members of the Boston life science community to present its life science innovation and partnership strategy and introduce the newly formed... Read More

Following in the footsteps of big pharma companies like Pfizer and Johnson & Johnson, global drugmaker Bayer AG today announced it’s setting up an innovation center in Cambridge Axel Bouchon is head of Bayer’s Life Science... Read More

When he was a medical student rotating through a local community hospital, Josh Mandel, M.D., was struck by an inefficiency he became determined to fix. Every morning, another medical student arrived at the ED at 5 a.m.... Read More

From a very early age, we’re taught the evils of drug addiction. No one ever starts off their lives aspiring to be an addict, and there’s a perception that anyone who is addicted to drugs belongs in the dregs of society. Read More

In a sun-filled conference room in Cambridge, Mass., on a recent day, Dr. Rosemary Mazanet held court at a meeting with the new drug team of the immunotherapy company Enumeral. In quick succession, the scientists updated... Read More